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WHAT IS CBD AND WHY SHOULD EMPLOYERS BE AWARE?
Leslie Jane E. Miyazono and Alexandra Dunn, PhD
College of Business, University of Mary Washington

INTRODUCTION

OBJECTIVE
This project will discuss the current classification, various
legislation, and approved uses of cannabis derived
products such as CBD. The need for various workplace
drug policies will also be reviewed. The purpose of this
project is to generate awareness to employers on the
evolving CBD marketplace and the multiple layers of
complexity of this topic in order to decide if current drug
policies need to be amended or revised.

Cannabidiol (CBD) is a chemical compound
present in the cannabis plant, which can be used
medicinally as a remedy for a variety of ailments
and pain management. The varying nature of
CBD products on the market may present some
obstacles for employers. Will CBD trigger a
positive test result and inadvertently violate a
valid workplace drug policy?

LEGISLATION
• CONTROLLED SUBSTANCES ACT OF 1971
• Classifies marijuana and its constituents such as
cannabinoids as a Schedule I drug.
• Schedule I controlled substances are described
as having a high potential for abuse, does not
have any current accepted medical use in
treatment in the U.S., has a high potential for
addition, and is identified as being not safe to
use even under medical supervision.

WHAT IS CBD?

WHAT IS THC?

Cannabidiol (CBD) is a chemical compound
that has been identified in the cannabis plant. It
has shown to bind very weakly, if at all, to
cannabinoid receptors. It is generally considered
not to produce a “high” or any other
intoxicating effect.

Delta-9 tetrahydrocannabinol (THC) is also a
chemical compound that has been identified in
the cannabis plant. It is the main psychoactive
compound which can produce a range of
psychedelic effects when combined with the
cannabinoid receptors located in the brain.

• AGRICULTURE IMPROVEMENT ACT OF 2018

• Permits the cultivation and production of the
hemp plant from an agricultural standpoint.
• Defines hemp as “the plant cannabis and any
part of the plant including derivatives and
cannabinoids, with a delta-9
tetrahydrocannabinol (THC) concentration of
not more than 0.3 percent on a dry weight
basis.”
• Removes hemp and derivates of cannabis with
extremely low concentrations (<0.3 %) of THC
from the definition of marijuana of the
Controlled Substances Act.

WHAT ARE EMPLOYER DRUG TESTING PROGRAMS?
Employers have a responsibility to provide a safe and productive workplace, free of potential accidents or
violence caused by the threat of drug abuse. A drug-free workplace policy should clearly prohibit the
manufacture, use, and distribution of controlled substances in the workplace and spell out the specific
consequences of violating this policy. Workplace drug-testing programs are designed to detect the
presence of alcohol, illicit drugs, or certain prescription drugs in the workplace.

WHAT ARE SOME IMPLICATIONS THAT CBD USE CAN
HAVE ON A WORKPLACE DRUG POLICY?

• DRUG FREE WORKPLACE ACT OF 1988
• Defines a drug-free workplace as “a workplace
where the unlawful manufacture, distribution,
dispensation, possession, or use of a controlled
substance is prohibited.”
• FOOD AND DRUG ADMINISTRATION
• Responsible for protecting the public health by
ensuring the safety, efficacy, and security of
human and veterinary drugs, biological
products, and medical devices.
• Has the final authority to regulate products
containing cannabis or cannabis-derived
compounds.
• Takes the position that because CBD is derived
from cannabis, it is a Schedule I substances;
therefore illegal under federal law. You cannot
receive a prescription for CBD to be filled at a
local pharmacy. CBD products are subject to
the same authorities and requirements,
regardless if they are classified as hemp under
the Agricultural Improvement Act of 2018.

Cannabidiol products including CBD
are not currently regulated by the
Food and Drug Administration
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• A mislabeled product that contains THC might produce intoxication, impairment, or may cause
an employee to fail a drug test.
• Mislabeled products on the market suggests that there should be a continued need for federal
and state regulation to ensure label accuracy of CBD consumer products

RECOMMENDATIONS TO EMPLOYERS
• Employers should understand the difference between hemp and marijuana and how the legislation in their
jurisdiction differentiates between the two substances. At this time, CBD is a substance that is not federally
regulated.
• For employers with a stated drug policy, it would be in their best interest to examine their current policy to
make sure it closely matches the company’s current legal, ethical, and business situation
• Educate the workforce on where they stand as far as tolerance on CBD use and inherent risks of CBD
products.
• A constructive, communicative approach between the employee and the employer should be encouraged
before any action is taken

